Inflammatory bowel disease: drugs cost $US7 million/year in Sweden

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1293, 2001-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Treatments for Inflammatory Bowel Disease

By Bodger Keith

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 387-401

Adis International

Access to resources Recommend Favorite

Costs of inflammatory bowel disease in the US substantial

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease: Current Perspectives

By Cipolla G. Crema F. Sacco S. Moro E. de PONTI F. Frigo G.

Pharmacological Research, Vol. 46, Iss. 1, 2002-07 ,pp. : 1-6

Academic Press

Access to resources Recommend Favorite

QSAR methods for the discovery of new inflammatory bowel disease drugs

By García-Domenech Ramón

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 933-949

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory Bowel Disease in the Elderly

By > Pardi Darrell S.

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 617-624

Adis International

Access to resources Recommend Favorite